Gilead Sciences & Satcher Health Leadership Institute at Morehouse School of Medicine Partner to Study Racial Health Inequiti...
July 28 2020 - 9:00AM
Business Wire
-- Funding from Gilead will support creation
of data map to systematically address the impact of the disease on
Black and minority communities --
Gilead Sciences, Inc. (Nasdaq: GILD) and the Satcher Health
Leadership Institute at Morehouse School of Medicine are working
together to develop a real-time, public-facing and comprehensive
health equity data platform to help address the impact of COVID-19
and other diseases on communities of color.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20200728005373/en/
The tool will provide the ability to collect and study the
demographic disparities associated with COVID-19, with the goal of
using this data to help create actionable, evidence-based policy
changes to attain health equity and ensure that disproportionately
impacted communities receive resources and support. The database
will also examine comorbidities associated with COVID-19, including
asthma, diabetes, heart disease, cancer, obesity, sickle cell
anemia and depression.
COVID-19 data demonstrate that the disease disproportionately
impacts racial and ethnic minority groups, particularly Black
Americans.
“As we have seen, COVID-19 is magnifying inequities that predate
the pandemic,” said Daniel E. Dawes, Director of the Satcher Health
Leadership Institute at Morehouse School of Medicine. “Black
Americans, Native Americans, Latinx Americans, Asian and Pacific
Islander Americans still contend with neighborhoods that are
largely devoid of health-sustaining and health-protective
resources, and they still contend with the political determinants
or drivers that created, perpetuated and exacerbated these health
inequities. We are honored to partner with Gilead to address the
root causes of health inequities. Our collective effort intends to
create systemic policy change and realize more equitable outcomes
for all population groups.”
Gilead will initially provide $1 million for the project and
also to support the creation of a Black Health Equity Alliance,
composed of national thought leaders, community representatives,
scholars, researchers and policymakers, which will help coordinate
COVID-19 education, training, information exchange and
dissemination, and policy analysis.
“The data we are compiling with the Satcher Health Leadership
Institute will provide the insight we need to help build a better
healthcare system for the Black community,” said Douglas M. Brooks,
Executive Director of Community Engagement at Gilead Sciences. “At
the core, the work we do at Gilead is being on the frontlines where
the need is greatest, as we’ve done in HIV and hepatitis C in
communities across the country. There are many hurdles in the
American healthcare system for the Black community to access care
and without data like this, we'll be having the same conversation
when the next pandemic strikes. We look forward to working with
Morehouse School of Medicine to help address these issues.”
Data show that in the United States, the Black community is
disproportionately impacted by COVID-19:
- Black people account for nearly 25 percent of the total number
of U.S. COVID-19 deaths, although they represent only 13 percent of
the country’s total population.
- Compared to white people, Black people have been nearly twice
as likely to die from the virus.
- An estimated 60 percent of COVID-19 deaths occurred in
disproportionately Black counties.
- Black people are approximately five times more likely to
contract COVID-19 than white people.
The data map will go live and be available to the public in the
fourth quarter of 2020.
About Satcher Health Leadership
Institute
The Satcher Health Leadership Institute (SHLI) aims to be the
leading transformational force for health equity in policy,
leadership development and research. Rooted in the legacy of its
founder, the 16th U.S. Surgeon General, Dr. David Satcher, SHLI’s
mission is to create systemic change at the intersection of policy
and equity by focusing on three priority areas: the political
determinants of health, health system transformation, and mental
and behavioral health. In conjunction with key strategic partners,
SHLI enhances leadership among diverse learners, conducts
forward-thinking research on the drivers of health inequities and
advances evidence-based policies, all in an effort to contribute to
the achievement of health equity for all population groups. Learn
more at https://satcherinstitute.org;
https://healthequitynetwork.org.
About Morehouse School of
Medicine
Morehouse School of Medicine (MSM), located in Atlanta, Ga.,
exists to improve the health and well-being of individuals and
communities, increase the diversity of the health professional and
scientific workforce and address primary health care through
programs in education, research and service, with emphasis on
people of color and the underserved urban and rural populations in
Georgia, the nation and the world. MSM is among the nation’s
leading educators of primary care physicians and has twice been
recognized as the top institution among U.S. medical schools for
its dedication to the social mission of education. The faculty and
alumni are noted in their fields for excellence in teaching,
research and public policy, and are known in the community for
exceptional, culturally appropriate patient care. Morehouse School
of Medicine is accredited by the Commission on Colleges of the
Southern Association of Colleges and Schools to award doctorate and
master’s degrees.
About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical
company that discovers, develops and commercializes innovative
medicines in areas of unmet medical need. The company strives to
transform and simplify care for people with life-threatening
illnesses around the world. Gilead has operations in more than 35
countries worldwide, with headquarters in Foster City,
California.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200728005373/en/
Gilead Contact: Chris Ridley, Media (908) 883-0478
http://www.gilead.com SHLI Contact: Bill Doughty, APR (720)
212-1290
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Sep 2023 to Sep 2024